Park Medi World IPO Subscription Day 2

Here, the Park Medi World IPO launched on 10th December 2025. Bidding for the issue will close today, 12th December 2025. The primary aim of the Park Medi World IPO is to raise ₹920.00 crores from the market. Also, the Park Medi World IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Park Medi World IPO subscription and details. 

Park Medi World IPO Details 

The price band for Riddhi Display Equipment’s IPO has been set at ₹154 to ₹162 per share, and a total of 5,67,90,124 shares are being issued. Let’s segregate the share quota fixed for different categories of investors. 

Park Medi World IPO Subscription Status

As of now, the Park Medi World IPO has been subscribed to 0.70 times. Of these, 0.85 times are subscribed by retail investors, 0.89 times by non-institutional investors, and 0.28 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Park Medi World’s IPO listing on 17th December 2025. Park Medi World also has a positive outlook behind the fresh issue of 4.75 crore shares, which will raise around Rs 920.00 crores.

Park Medi World IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Park Medi World IPO GMP for 11th December 2025. 

The grey market premium for this IPO has surged to 7.41% or Rs 12.00 per share. It indicates that the estimated listing price per share is Rs 174.00. Numerous factors played a pivotal role in this jump in the GMP of Riddhi Display Equipment’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs. 

About Park Medi World Ltd.

Park Medi World was established in 2011. Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025. The company operates 14 multi-speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also certified by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan. Park Hospital offers more than 30 super speciality and speciality services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.

Park Medi World Limited Financials

The company’s financial analysis is essential before applying for the Park Medi World IPO. Look at the table to learn about Park Medi World Limited’s financials. 

Explanation

Park Medi World Limited’s revenue increased by 13% from ₹1,263.08 crores in March 2024  to ₹1,425.97 crores in March 2025. Moreover, the company’s PAT increased by 40% from ₹152.01 crores in March 2024 to ₹213.22 crores in March 2025.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Park Medi World IPO.

Park Medi World IPO Listing Expectations

Park Medi World IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 7.41% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 174.00.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation. 

Park Medi World IPO Dates

Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Park Medi World IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?